← Back to Search

Intervention Group (Cohorting) for COVID-19 (CERO Trial)

N/A

Waitlist Available

Led By Joshua Chodosh, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must be employees of ArchCare

Family members of residents who reside at either TCC or MMW (ArchCare facilities)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to month 5

Awards & highlights

CERO Trial Summary

The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are: To rapidly plan and pilot test an intervention that leverages COVID-19 antibody and PCR status to pair SNF staff with residents in the safest way possible To reduce reduced COVID-19 incidence rate compared to SNFs not using this novel staff-resident assignment strategy.

Eligible Conditions

COVID-19
Coronavirus

CERO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

CERO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to month 5

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to month 5

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to month 5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of New COVID-19 Detected Infections Among Residents

Secondary outcome measures

Number of Hospitalizations Over Time

Number of New COVID-19 Detected Infections Among Staff

CERO Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention Group (Cohorting)Experimental Treatment1 Intervention

Group II: Control Group (No Cohorting)Active Control1 Intervention

0 / 10Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brown UniversityOTHER

456 Previous Clinical Trials

562,994 Total Patients Enrolled

1 Trials studying COVID-19

23,768 Patients Enrolled for COVID-19

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

839,634 Total Patients Enrolled

18 Trials studying COVID-19

58,475 Patients Enrolled for COVID-19

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,005,027 Total Patients Enrolled

14 Trials studying COVID-19

22,575,447 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research study still need participants?

"The clinicaltrial.gov database shows that this medical study is not actively recruiting participants, as the last update was on November 3rd 2022. Although no longer open for enrolment, 1032 other studies are welcoming patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVID-19 Serologic Strategies for Skilled Nursing Facilities

2021. "COVID-19 Serologic Strategies for Skilled Nursing Facilities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05270980.